Wedge Capital Management L L P NC Buys 37,899 Shares of DaVita Inc. (NYSE:DVA)

Wedge Capital Management L L P NC lifted its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 17.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 259,906 shares of the company's stock after buying an additional 37,899 shares during the period. Wedge Capital Management L L P NC owned about 0.32% of DaVita worth $39,758,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. United Capital Financial Advisors LLC lifted its stake in shares of DaVita by 2.6% in the 4th quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock valued at $361,000 after purchasing an additional 62 shares during the last quarter. Freedom Investment Management Inc. raised its holdings in DaVita by 3.6% during the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock valued at $268,000 after buying an additional 62 shares during the period. Wealth Enhancement Advisory Services LLC lifted its position in DaVita by 2.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock worth $531,000 after buying an additional 69 shares during the last quarter. UMB Bank n.a. boosted its stake in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after buying an additional 76 shares during the period. Finally, Coppell Advisory Solutions LLC increased its position in DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

DaVita Trading Down 0.1%

DaVita stock traded down $0.14 during trading hours on Monday, hitting $137.76. The company had a trading volume of 566,225 shares, compared to its average volume of 820,529. The firm has a market cap of $10.40 billion, a P/E ratio of 12.83, a P/E/G ratio of 1.07 and a beta of 1.11. The company has a 50-day moving average price of $142.56 and a two-hundred day moving average price of $151.99. DaVita Inc. has a 1 year low of $131.76 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The firm had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. DaVita had a return on equity of 115.48% and a net margin of 7.31%. DaVita's quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.26 earnings per share. On average, sell-side analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on DVA shares. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Cowen restated a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Truist Financial cut their target price on DaVita from $170.00 to $164.00 and set a "hold" rating on the stock in a research note on Monday, May 19th. Finally, Barclays raised their price target on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $164.50.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.